HOME › DRUGS › PEGINTERFERON ALFA-2B
ACTIVE SUBSTANCE / INN

PEGINTERFERON ALFA-2B

Brand name(s): PegIntron, Cylatron, SYLATRON, PEGINTRON, ViraferonPeg
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
WITHDRAWN
Hepatitis C, Chronic
BLA103949
ACTIVE SUBSTANCE
Peginterferon Alfa-2B
REGULATORS
FDA · EMA
SPONSORS / MAH
SCHERING, SP Europe, Merck Sharp & Dohme B.V.
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PEGINTRONBLA103949SCHERINGPrescription
SYLATRONBLA103949SCHERINGPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PegIntronMerck Sharp & Dohme B.V.Withdrawn24/05/2000Hepatitis C, Chronic
ViraferonPegMerck Sharp Dohme Ltd Withdrawn28/05/2000Hepatitis C, Chronic
CylatronSP EuropeApplication withdrawnMelanoma

FULL INTELLIGENCE ON PEGINTERFERON ALFA-2B

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →